CLINICAL_TRIALS
trial_result
· 2026-01-05
Clinical Trial Update: C-TIL051 in Non-Small Cell Lung Cancer [Phase 1]
Summary
A Phase 1 clinical trial evaluating C-TIL051 for metastatic non-small cell lung cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbelZeta Inc. | Conditions: Metastatic Non Small Cell Lung Cancer | Phase 1 | Status: TERMINATED